Chronic Myeloid Leukemia in Bulgaria in the New Millennium: Identification of Directions for Improvement in Management and Outcomes Reporting

Background: In the last two decades, tyrosine kinase inhibitors (TKIs) and advances in molecular diagnostics have revolutionized management and long-term clinical outcomes in chronic myeloid leukemia (CML). Real-world data from different countries allow for the identification of country-specific iss...

Full description

Bibliographic Details
Main Authors: Velizar Shivarov, Denitsa Grigorova, Mira Nedeva, Todor Milkov, Albena Zlatareva, Angel Yordanov
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Hemato
Subjects:
Online Access:https://www.mdpi.com/2673-6357/5/3/22